294 related articles for article (PubMed ID: 32284967)
1. In vivo priming of human mesenchymal stem cells with hepatocyte growth factor-engineered mesenchymal stem cells promotes therapeutic potential for cardiac repair.
Park BW; Jung SH; Das S; Lee SM; Park JH; Kim H; Hwang JW; Lee S; Kim HJ; Kim HY; Jung S; Cho DW; Jang J; Ban K; Park HJ
Sci Adv; 2020 Mar; 6(13):eaay6994. PubMed ID: 32284967
[TBL] [Abstract][Full Text] [Related]
2. In Situ Preconditioning of Human Mesenchymal Stem Cells Elicits Comprehensive Cardiac Repair Following Myocardial Infarction.
Sim WS; Park BW; Ban K; Park HJ
Int J Mol Sci; 2021 Feb; 22(3):. PubMed ID: 33535594
[TBL] [Abstract][Full Text] [Related]
3. [Hepatocyte growth factor did not enhance the effects of bone marrow-derived mesenchymal stem cells transplantation on cardiac repair in a porcine acute myocardial infarction model].
Ma DC; Yang ZJ; Wang W; Xu SL; Zhang YQ; Zhou F; Chen B; Xu ZQ; Cao KJ; Ma WZ
Zhonghua Xin Xue Guan Bing Za Zhi; 2006 Feb; 34(2):119-22. PubMed ID: 16626576
[TBL] [Abstract][Full Text] [Related]
4. Enhanced cell survival and paracrine effects of mesenchymal stem cells overexpressing hepatocyte growth factor promote cardioprotection in myocardial infarction.
Zhao L; Liu X; Zhang Y; Liang X; Ding Y; Xu Y; Fang Z; Zhang F
Exp Cell Res; 2016 May; 344(1):30-39. PubMed ID: 27025401
[TBL] [Abstract][Full Text] [Related]
5. Experimental study of bone marrow-derived mesenchymal stem cells combined with hepatocyte growth factor transplantation via noninfarct-relative artery in acute myocardial infarction.
Yang ZJ; Ma DC; Wang W; Xu SL; Zhang YQ; Chen B; Zhou F; Zhu TB; Wang LS; Xu ZQ; Zhang FM; Cao KJ; Ma WZ
Gene Ther; 2006 Nov; 13(22):1564-8. PubMed ID: 16810195
[TBL] [Abstract][Full Text] [Related]
6. Effects of hepatocyte growth factor overexpressed bone marrow-derived mesenchymal stem cells on prevention from left ventricular remodelling and functional improvement in infarcted rat hearts.
Wang S; Qin X; Sun D; Wang Y; Xie X; Fan W; Wang Y; Liang D; Pei X; Cao F
Cell Biochem Funct; 2012 Oct; 30(7):574-81. PubMed ID: 22592978
[TBL] [Abstract][Full Text] [Related]
7. AKT-modified autologous intracoronary mesenchymal stem cells prevent remodeling and repair in swine infarcted myocardium.
Yu YS; Shen ZY; Ye WX; Huang HY; Hua F; Chen YH; Chen K; Lao WJ; Tao L
Chin Med J (Engl); 2010 Jul; 123(13):1702-8. PubMed ID: 20819633
[TBL] [Abstract][Full Text] [Related]
8. C-Kit Positive Cardiac Stem Cells and Bone Marrow-Derived Mesenchymal Stem Cells Synergistically Enhance Angiogenesis and Improve Cardiac Function After Myocardial Infarction in a Paracrine Manner.
Bao L; Meng Q; Li Y; Deng S; Yu Z; Liu Z; Zhang L; Fan H
J Card Fail; 2017 May; 23(5):403-415. PubMed ID: 28284757
[TBL] [Abstract][Full Text] [Related]
9. Mesenchymal stem cells modified with stromal cell-derived factor 1 alpha improve cardiac remodeling via paracrine activation of hepatocyte growth factor in a rat model of myocardial infarction.
Tang J; Wang J; Guo L; Kong X; Yang J; Zheng F; Zhang L; Huang Y
Mol Cells; 2010 Jan; 29(1):9-19. PubMed ID: 20016947
[TBL] [Abstract][Full Text] [Related]
10. Role of interleukin-7 in fusion of rat bone marrow mesenchymal stem cells with cardiomyocytes in vitro and improvement of cardiac function in vivo.
Haneef K; Ali A; Khan I; Naeem N; Jamall S; Salim A
Cardiovasc Ther; 2018 Dec; 36(6):e12479. PubMed ID: 30451388
[TBL] [Abstract][Full Text] [Related]
11. Pretreatment of human mesenchymal stem cells with pioglitazone improved efficiency of cardiomyogenic transdifferentiation and cardiac function.
Shinmura D; Togashi I; Miyoshi S; Nishiyama N; Hida N; Tsuji H; Tsuruta H; Segawa K; Tsukada Y; Ogawa S; Umezawa A
Stem Cells; 2011 Feb; 29(2):357-66. PubMed ID: 21732492
[TBL] [Abstract][Full Text] [Related]
12. Absence of NUCKS augments paracrine effects of mesenchymal stem cells-mediated cardiac protection.
Zhang Y; Chiu S; Liang X; Chai YH; Qin Y; Wang J; Li X; Qiu B; Tergaonkar V; Tse HF; Lian Q
Exp Cell Res; 2017 Jul; 356(1):74-84. PubMed ID: 28412246
[TBL] [Abstract][Full Text] [Related]
13. Anti-oxidant activity reinforced reduced graphene oxide/alginate microgels: Mesenchymal stem cell encapsulation and regeneration of infarcted hearts.
Choe G; Kim SW; Park J; Park J; Kim S; Kim YS; Ahn Y; Jung DW; Williams DR; Lee JY
Biomaterials; 2019 Dec; 225():119513. PubMed ID: 31569016
[TBL] [Abstract][Full Text] [Related]
14. Chitosan/silk fibroin modified nanofibrous patches with mesenchymal stem cells prevent heart remodeling post-myocardial infarction in rats.
Chen J; Zhan Y; Wang Y; Han D; Tao B; Luo Z; Ma S; Wang Q; Li X; Fan L; Li C; Deng H; Cao F
Acta Biomater; 2018 Oct; 80():154-168. PubMed ID: 30218777
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic effect of hepatocyte growth factor-overexpressing bone marrow-derived mesenchymal stem cells on CCl
Zhang Y; Li R; Rong W; Han M; Cui C; Feng Z; Sun X; Jin S
Cell Death Dis; 2018 Dec; 9(12):1186. PubMed ID: 30538216
[TBL] [Abstract][Full Text] [Related]
16. Immunomodulation by systemic administration of human-induced pluripotent stem cell-derived mesenchymal stromal cells to enhance the therapeutic efficacy of cell-based therapy for treatment of myocardial infarction.
Sun SJ; Lai WH; Jiang Y; Zhen Z; Wei R; Lian Q; Liao SY; Tse HF
Theranostics; 2021; 11(4):1641-1654. PubMed ID: 33408772
[No Abstract] [Full Text] [Related]
17. Pre-treatment of mesenchymal stem cells with a combination of growth factors enhances gap junction formation, cytoprotective effect on cardiomyocytes, and therapeutic efficacy for myocardial infarction.
Hahn JY; Cho HJ; Kang HJ; Kim TS; Kim MH; Chung JH; Bae JW; Oh BH; Park YB; Kim HS
J Am Coll Cardiol; 2008 Mar; 51(9):933-43. PubMed ID: 18308163
[TBL] [Abstract][Full Text] [Related]
18. MSCs transfected with hepatocyte growth factor or vascular endothelial growth factor improve cardiac function in the infarcted porcine heart by increasing angiogenesis and reducing fibrosis.
Lu F; Zhao X; Wu J; Cui Y; Mao Y; Chen K; Yuan Y; Gong D; Xu Z; Huang S
Int J Cardiol; 2013 Sep; 167(6):2524-32. PubMed ID: 22981278
[TBL] [Abstract][Full Text] [Related]
19. Effects of hepatocyte growth factor gene-transfected mesenchymal stem cells on dimethylnitrosamine-induced liver fibrosis in rats.
Moon SH; Lee CM; Park SH; Jin Nam M
Growth Factors; 2019 Aug; 37(3-4):105-119. PubMed ID: 31452434
[TBL] [Abstract][Full Text] [Related]
20. Transplantation of mesenchymal stem cells preconditioned with diazoxide, a mitochondrial ATP-sensitive potassium channel opener, promotes repair of myocardial infarction in rats.
Cui X; Wang H; Guo H; Wang C; Ao H; Liu X; Tan YZ
Tohoku J Exp Med; 2010 Feb; 220(2):139-47. PubMed ID: 20139665
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
